Cas:946-39-4 ethyl trans-2-phenylcyclopropanecarboxylate manufacturer & supplier

We serve Chemical Name:ethyl trans-2-phenylcyclopropanecarboxylate CAS:946-39-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl trans-2-phenylcyclopropanecarboxylate

Chemical Name:ethyl trans-2-phenylcyclopropanecarboxylate
CAS.NO:946-39-4
Synonyms:(1R,2R)-ethyl 2-phenylcyclopropane-1-carboxylate
Molecular Formula:C12H14O2
Molecular Weight:190.23800
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:266.7ºC at 760mmHg
Density:1.108g/cm3
Index of Refraction:1.54
PSA:26.30000
Exact Mass:190.09900
LogP:2.35320

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (1R,2R)-ethyl 2-phenylcyclopropane-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R,2R)-ethyl 2-phenylcyclopropane-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,2R)-ethyl 2-phenylcyclopropane-1-carboxylate Use and application,(1R,2R)-ethyl 2-phenylcyclopropane-1-carboxylate technical grade,usp/ep/jp grade.


Related News: Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. [Pd(C6H2(CH=N-C6H4Me-4)-2-(Pd(μ-OAc))-4-(CH=N-C6H4Me-4)-5)(μ-OAc)]n manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 3,5,8-triethyl-1′,2,4,6,7,8′-hexamethyl-a,c-biladiene dihydrobromide suppliers Setting up of these plants will make the country self-reliant to a large extent in respect of these bulk drugs, it noted. N1-[5-(4,5-Dihydrobenzo[2,3]thiepino[4,5-d][1,3]thiazol-2-ylamino)pentyl]-2,4-difluoro-1-benzenesulfonamide vendor & factory.